Researchers in Ontario, Quebec and Nova Scotia are launching a project to map more than 10,000 genomes from Black Canadians with Type 2 diabetes, high blood pressure and an aggressive form of breast cancer. Project leaders hope their findings eventually help target treatment and preventive care and contribute to better health outcomes for racialized patients.